Webinars » Robotic Automation of Cell Isolation with CytoSinct™ 1000 to Streamline Cell Therapy Manufacturing

Robotic Automation of Cell Isolation with CytoSinct™ 1000 to Streamline Cell Therapy Manufacturing

Cell therapy manufacturing has long been constrained by manual bottlenecks - steps that are labor-intensive, variable, and difficult to scale. Robotic automation is increasingly becoming key to scaling the manufacturing of these therapies. By standardizing critical workflows and operating seamlessly with GMP-compliant instruments, robots enable levels of throughput, reproducibility, and efficiency that were previously out of reach.

In this talk, Dr. Fred Parietti, co-founder and CEO of Multiply Labs, will share how robotic biomanufacturing clusters are redefining what’s possible inside the cleanroom. As a case study, he will highlight the integration of the GenScript CytoSinct™ 1000 into the Multiply Labs robotic platform. This fully automated cell isolation workflow demonstrates how robotics can deliver higher consistency, streamline operations, and shorten production timelines - all while operating with validated, industry-leading tools.

Attendees will learn how robotics improves the unit economics of cell therapy manufacturing, enables parallelism for higher throughput, and accelerates the automation process. More than incremental efficiency, this approach points to a new standard for scalable, automated cell therapy production.

Learn About

How robotics radically improves the unit economics of cell therapy manufacturing, increasing throughput, and accelerating timelines?

How the robotic system overcomes potential regulatory and process barriers by operating market-leading GMP instruments that are already deployed?

How can cell isolation be robotic automated utilizing GenScript CytoSinct and Multiply lab platform?

In this webinar, you will learn
Please enter a valid first name.
Please enter a valid last name.
Please enter a valid email address.
Please enter a valid telephone number.
Please enter a valid job title.
Please enter a valid institution/company.

Webinar Details

  • Date: OCT 15, 2025
  • Time: 2:30 PM PDT
  • Speaker:
Fred Parietti Dr. Fred Parietti, Ph.D.

CEO, Multiply Lab

Fred is the Co-founder and CEO of Multiply Labs, a robotics company developing industry-leading automated manufacturing systems to produce individualized drugs. Founded in 2016, the company’s mission is to scale patient access to cell therapies and other individualized medicines.
Under Fred’s leadership, the company created the first cell therapy robotics system to be compatible with existing, market-leading GMP equipment. This means cell therapy manufacturers can scale without significantly changing their existing processes, minimizing process and regulatory risk. Additionally, Multiply Labs brought to market the first technology to manufacture individualized pharmaceutical capsules at industrial scale.
Fred holds a PhD in Mechanical Engineering from the Massachusetts Institute of Technology. He has co-authored 30+ peer-reviewed robotics publications and 12+ patents and patent applications, which have been cited more than 2,000 times. Prior to his research at MIT, Fred worked on robotics at Carnegie Mellon University, ETH Zurich, and Polytechnic University of Milan.

Speaker-related Webinars

Latest Webinars

Find More Catalog Product Categories »
Robotic Automation of Cell Isolation with CytoSinct™ 1000 to Streamline Cell Therapy Manufacturing

Robotic Automation of Cell Isolation with CytoSinct™ 1000 to Streamline Cell Therapy Manufacturing

Nov 21, 2025
Unlock Cell Therapy Potential with Customizable Cell Isolation and Enhanced T cell Activation Solution

Unlock Cell Therapy Potential with Customizable Cell Isolation and Enhanced T cell Activation Solution

Nov 21, 2025
Unlock a New Era of Automated Mini and Maxi-Scale Plasmid Purification with AmMag™ Quatro Solutions

Unlock a New Era of Automated Mini and Maxi-Scale Plasmid Purification with AmMag™ Quatro Solutions

Nov 21, 2025